Corient Private Wealth’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32M Sell
152,883
-19,770
-11% -$4.26M 0.05% 306
2025
Q4
$34.4M Buy
172,653
+91,060
+112% +$17.1M 0.02% 439
2025
Q3
$12.8M Buy
81,593
+157
+0.2% +$24.3K 0.02% 475
2025
Q2
$13.7M Sell
81,436
-6,450
-7% -$957K 0.02% 458
2025
Q1
$12.1M Sell
87,886
-3,804
-4% -$485K 0.02% 478
2024
Q4
$10.8M Buy
91,690
+617
+0.7% +$72K 0.02% 494
2024
Q3
$10.1M Sell
91,073
-2,429
-3% -$254K 0.02% 559
2024
Q2
$9.19M Sell
93,502
-125,455
-57% -$12.8M 0.02% 550
2024
Q1
$24.5M Sell
218,957
-18,055
-8% -$1.95M 0.04% 349
2023
Q4
$23.9M Buy
237,012
+481
+0.2% +$47.7K 0.04% 348
2023
Q3
$20.5M Buy
236,531
+582
+0.2% +$52.6K 0.05% 341
2023
Q2
$22.3M Buy
235,949
+161,656
+218% +$13.7M 0.05% 312
2023
Q1
$5.61M Buy
74,293
+10,104
+16% +$762K 0.02% 557
2022
Q4
$4.94M Buy
+64,189
New +$4.88M 0.02% 508

Other funds holding CAH

Corient Private Wealth's CAH Position: Q1 2026 in Review

Corient Private Wealth reduced its Cardinal Health (CAH) stake by 11% in Q1 2026, selling an estimated $4.26M and leaving 152,883 shares worth $32M. The position accounts for 0.05% of the portfolio, ranked #306.

Corient Private Wealth first reported a position in CAH in Q4 2022 and has held it in 14 quarters since. The position peaked at $34.4M in Q4 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Corient Private Wealth held 152,883 shares of Cardinal Health worth $32M as of Q1 2026.
  • Corient Private Wealth sold 19,770 Cardinal Health shares in Q1 2026, an estimated $4.26M.
  • Cardinal Health made up 0.05% of Corient Private Wealth's portfolio in Q1 2026, its #306 holding.
  • Corient Private Wealth first reported a position in Cardinal Health in Q4 2022 and has held it in 14 quarters since.
  • Corient Private Wealth's Cardinal Health position peaked at $34.4M in Q4 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.